Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Rolling NDA commences for Lucassin in hepatorenal syndrome type 1

May 29, 2008

FDA accepts for filing Watson's NDA for oxybutynin chloride topical gel for overactive bladder

May 29, 2008

PNU-165442G improves stress urinary incontinence in women in phase II study

May 27, 2008

Indevus licenses Canadian rights for Sanctura XR to Allergan

May 23, 2008

Omeros initiates patient enrollment in phase I OMS-201 study

May 22, 2008

Protox initiates dosing in phase II clinical trial of PRX-302 in BPH

May 19, 2008

AEterna Zentaris initiates dosing in phase III safety trial of cetrorelix in BPH

May 16, 2008

Recent Astellas patent describes new compounds for treating urinary incontinence

May 14, 2008

BMP receives SFDA acceptance for Enablex clinical trial

May 9, 2008

Nymox announces that 3 year follow-up study of NX-1207 for BPH is near completion

May 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...